Amyloid-β and tau PET scans predict clinical progression in cognitively unimpaired people

被引：2
|
作者：
Ossenkoppele, Rik [1 ]
Hansson, Oskar [1 ]
Hampel, Harald [2 ]
机构：
[1] Lund Univ, Clin Memory Res Unit, Lund, Sweden
[2] Eisai Inc, Nutley, NJ USA
来源：
NATURE MEDICINE | 2022年 / 28卷 / 11期
关键词：
D O I：
10.1038/s41591-022-02071-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Evidence — provided by a combination of amyloid-β and tau PET examinations — of advanced Alzheimer’s disease pathological changes in the brain in cognitively unimpaired individuals is strongly associated with short-term (3–5 years) cognitive decline. Thus, amyloid-β and tau PET have high clinical relevance.
引用
收藏
页码：2267 / 2268
页数：2
相关论文
共 50 条
  • [41] Amyloid-β deposition predicts oscillatory slowing of magnetoencephalography signals and a reduction of functional connectivity over time in cognitively unimpaired adults
    Scheijbeler, Elliz P.
    de Haan, Willem
    Coomans, Emma M.
    den Braber, Anouk
    Tomassen, Jori
    ten Kate, Mara
    Konijnenberg, Elles
    Collij, Lyduine E.
    van de Giessen, Elsmarieke
    Barkhof, Frederik
    Visser, Pieter Jelle
    Stam, Cornelis J.
    Gouw, Alida A.
    BRAIN COMMUNICATIONS, 2025, 7 (01)
  • [42] Amyloid and tau PET relate to memory loss in cognitively normal individuals: the SCIENCe project
    Wolters, E.
    Timmers, T.
    Ossenkoppele, R.
    Verfaillie, S. C. J.
    Visser, D.
    Scheltens, P.
    Schmidt, M. E.
    van den Bosch, K.
    Boellaard, R.
    Golla, S. S. V.
    van der Flier, W. M.
    van Berckel, B. N. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S179 - S179
  • [43] DualNet: a Deep Neural Network to Predict Individual Tau and Amyloid PET Images from a Combined Dose Image using the Disambiguation of Dual Dose Amyloid-Tau PET Scans Using The ADNI Dataset
    Macdonald, Todd
    Chen, Kevin
    Koran, Mary Ellen
    Moseley, Michael
    Zaharchuk, Greg
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [44] CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
    Hansson, Oskar
    Seibyl, John
    Stomrud, Erik
    Zetterberg, Henrik
    Trojanowski, John Q.
    Bittner, Tobias
    Lifke, Valeria
    Corradini, Veronika
    Eichenlaub, Udo
    Batrla, Richard
    Buck, Katharina
    Zink, Katharina
    Rabe, Christina
    Blennow, Kaj
    Shaw, Leslie M.
    ALZHEIMERS & DEMENTIA, 2018, 14 (11) : 1470 - 1481
  • [45] Association of amyloid-β CSF/PET discordance and tau load 5 years later
    Reimand, Juhan
    Collij, Lyduine
    Scheltens, Philip
    Bouwman, Femke
    Ossenkoppele, Rik
    NEUROLOGY, 2020, 95 (19) : E2648 - E2657
  • [46] Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β-negative cognitively normal individuals
    Groot, Colin
    Dore, Vincent
    Robertson, Joanne
    Burnham, Samantha C.
    Savage, Greg
    Ossenkoppele, Rik
    Rowe, Christopher C.
    Villemagne, Victor L.
    NEUROBIOLOGY OF AGING, 2021, 97 : 41 - 48
  • [47] Witnessed Apneas During Sleep are Associated with Elevated Tau-PET Signal in the Entorhinal Cortex in Cognitively Unimpaired Elderly
    Carvalho, Diego
    St Louis, Erik
    Boeve, Bradley
    Schwarz, Christopher
    Przybelski, Scott
    Knopman, David
    Lowe, Val
    Mielke, Michelle
    Reddy, Ashritha
    Petersen, Ronald
    Jack, Clifford
    Vemuri, Prashanthi
    NEUROLOGY, 2019, 92 (15)
  • [48] Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
    Idland, Ane-Victoria
    Sala-Llonch, Roser
    Watne, Leiv Otto
    Braekhus, Anne
    Hansson, Oskar
    Blennow, Kaj
    Zetterberg, Henrik
    Sorensen, Oystein
    Walhovd, Kristine Beate
    Wyller, Torgeir Bruun
    Fjell, Anders Martin
    NEUROBIOLOGY OF AGING, 2020, 93 : 1 - 15
  • [49] Association of Vascular Risk Factors With β-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use
    Kobe, Theresa
    Gonneaud, Julie
    Binette, Alexa Pichet
    Meyer, Pierre-Francois
    McSweeney, Melissa
    Rosa-Neto, Pedro
    Breitner, John C. S.
    Poirier, Judes
    Villeneuve, Sylvia
    Aisen, Paul
    Anthal, Elena
    Appleby, Melissa
    Ayranci, Gulebru
    Bellec, Pierre
    Bohbot, Veronique
    Carmo, Leopoldina
    Chakravarty, Mallar
    Cheewakriengkrai, Laksanun
    Collins, Louis
    Daoust, Leslie-Ann
    Dauar-Tedeschi, Marina
    Dea, Doris
    Debacker, Clement
    Duclair, Guerda
    Dufour, Marianne
    El-Khoury, Rana
    Etienne, Pierre
    Evans, Alan
    Ferdinand, Fabiola
    Fontaine, David
    Frappier, Josee
    Frenette, Joanne
    Gagne, Guylaine
    Gauthier, Serge
    Gervais, Valerie
    Giles, Renuka
    Gordon, Renee
    Hoge, Rick
    Ruda-Medina, Yasser
    Kat, Justin
    Kazazian, Christina
    Labonte, Anne
    Lafaille-Magnan, Marie-Elyse
    Lee, Tanya
    Leppert, Illana
    Madjar, Cecile
    Mahar, Laura
    Malta, Jean-Robert
    Mayrand, Ginette
    Miron, Justin
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [50] Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults
    McGrath, Emer R.
    Beiser, Alexa S.
    O'Donnell, Adrienne
    Yang, Qiong
    Ghosh, Saptaparni
    Gonzales, Mitzi M.
    Himali, Jayandra J.
    Satizabal, Claudia L.
    Johnson, Keith A.
    Tracy, Russell P.
    Seshadri, Sudha
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 87 (04) : 1517 - 1526
12345